Solace Chew
Natural health product licensed in Canada
- Other names
- Fre, Solace
- Licence holder
- 10233625 Canada Corp (dba ReCreation Marketing)
- NPN or DIN-HM
- 80112518
- Status
- Active licence
- Licence date
- 31 August 2021
- Revision date
- Not provided
- Route of administration
- Buccale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 1-Méthyl-2-(3-pyridyl)pyrrolidine Source : Nicotine polacrilex | 4 mg |
Non-medicinal ingredients
Acacia, Talc, Saveur de menthe, Laque Rouge 40, Saveur de cannelle, Sucralose, Bicarbonate de sodium, Carbonate de sodium, l-Menthol, Saveur, Sorbitol, Saccharine, Bleu 1, Sirop de maltitol, Cire de Carnauba, Base de gomme, Saveur de fruit naturelle, Acésulfame potassium, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 | minimum: 1 Tous les jours ; maximum: 9 Tous les jours |
| Adultes | minimum: 18 years | 1 | minimum: 1 Tous les jours ; maximum: 7 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Reduces withdrawal symptoms associated with quitting smoking. .As a temporary aid to those who want to stop smoking cigarettes or break the cigarette habit, when used as part of a smoking cessation program.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112518
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.